Avalere Health

Avalere Health is a global healthcare consulting firm that provides integrated advisory, medical, and marketing services across the product lifecycle. The company operates with a mission to make "Every Patient Possible," working with pharmaceutical, biotechnology, and other healthcare organizations to address market access, regulatory, and commercialization challenges.

The firm employs a proprietary strategic framework called "Sense Making" that analyzes the intersection of science, society, and systems to develop healthcare solutions. Their service lines span market access and regulatory strategy, medical communications and scientific storytelling, and brand marketing. The company maintains global expert panels of leading clinicians in oncology-hematology, hepatology, and dermatology, and employs healthcare specialists with significant PhD representation on staff.

Avalere Health operates offices in multiple cities worldwide and recently joined NBCUniversal's The Care Collective to transform healthcare media. The organization emphasizes diversity and inclusion, with unconscious bias training provided to their global HR team and a majority female workforce.

Organizations should consider Avalere Health when they need comprehensive, integrated support across the product lifecycle—from regulatory strategy and evidence generation through market access and commercial launch. The firm's ability to coordinate advisory, medical, and marketing functions under a unified strategic framework can streamline decision-making for complex therapeutic launches.

Expect a consultative approach grounded in the company's "Sense Making" methodology, with access to specialized clinical expertise through their expert panels. The recent partnership with NBCUniversal suggests evolving capabilities in patient engagement and healthcare media that may benefit brands seeking innovative communication channels.

Avalere Health exclusively serves the healthcare industry with particular strength in pharmaceutical and biotechnology market access. The company's expertise spans regulatory strategy, payer engagement, health economics and outcomes research (HEOR), and patient support program development. Their therapeutic area depth in oncology-hematology, hepatology, and dermatology—supported by dedicated expert clinical panels—demonstrates specialized capabilities in complex specialty drug markets requiring sophisticated evidence development and commercialization strategies.

Mid-to-large pharmaceutical and biotechnology companies developing innovative therapies who require coordinated market access, regulatory, and commercialization support across multiple geographies. Organizations with complex payer landscapes, specialty therapeutic areas (particularly oncology-hematology, hepatology, or dermatology), or patient engagement challenges will find aligned expertise.